Skip to content
Clinical Trials – home

Psoriasis Diagnostics

15 / 53 trials open to patients21 countries

In short

Psoriasis is a chronic skin condition that requires proper diagnosis to distinguish it from other skin disorders and to guide treatment decisions. While most cases can be identified through a simple physical examination, understanding when to seek diagnostic testing and what tests might be needed is important for anyone experiencing symptoms or participating in research studies.

Key points

  • Most psoriasis cases can be diagnosed simply by looking at your skin, without the need for complex tests.
  • A skin biopsy is only needed in rare cases when the diagnosis is uncertain or to rule out other conditions.
  • Psoriasis is not contagious and cannot be spread from person to person through touch or close contact.
  • About one in three people with psoriasis will also develop psoriatic arthritis, making regular joint assessment important.
  • Clinical trials use specific diagnostic criteria to determine eligibility, including baseline health assessments and severity measurements.
  • People with psoriasis should be monitored for related conditions like heart disease, diabetes, and depression.
  • The condition affects people of all skin colors differently in appearance, with patches showing various shades depending on skin tone.
  • While psoriasis is a lifelong condition, effective treatments are available that can help most people manage their symptoms successfully.

Introduction: Who Needs Psoriasis Diagnostics

If you notice unusual skin changes, it is important to know when to seek medical attention. People who develop thick, scaly patches of skin that are itchy or uncomfortable should consider seeing a healthcare provider for evaluation. These patches often appear on the elbows, knees, scalp, or lower back, but can show up anywhere on the body.

Early diagnosis matters because psoriasis is not just a cosmetic concern. It is an autoimmune condition, which means your immune system mistakenly attacks healthy skin cells, causing inflammation throughout your body. This inflammation can affect other parts of your body beyond your skin. About one in three people with psoriasis also develop a related condition called psoriatic arthritis, which causes painful and swollen joints.

You should seek diagnostic evaluation if you experience red, brown, or purple patches of skin covered with thick, raised areas that flake or scale. The appearance can vary depending on your skin tone. On lighter skin, patches typically appear red with silvery white scales. On darker skin tones, the patches may appear purple, grayish, or darker brown, and the scales may look grey.

Anyone experiencing persistent skin symptoms should not delay seeking care. While psoriasis most commonly starts between ages 15 and 25, or between ages 50 and 60, it can begin at any age. Men and women are equally affected, and people of all skin colors can develop this condition.

Classic Diagnostic Methods

The diagnosis of psoriasis is primarily clinical, meaning that doctors can usually identify it by looking at your skin. When you visit a healthcare provider, they will conduct a thorough examination that involves several steps to reach an accurate diagnosis.

Physical Examination

Your healthcare provider will carefully examine your skin, scalp, and nails. They will look at the appearance of any patches or lesions, noting characteristics like thickness, color, and the presence of scales. The location of these patches is also important, as psoriasis tends to appear in certain areas more commonly than others.

During the examination, your doctor will assess the itchiness of your skin. Itching is a common symptom of psoriasis and helps distinguish it from other skin conditions. They will also check your fingernails and toenails, as changes in the nails can provide important clues. Nail changes in psoriasis may include small pits or dents, discoloration, thickening, or separation of the nail from the nail bed.

Medical History Review

Your healthcare provider will ask detailed questions about your symptoms and medical history. They will want to know when the symptoms started, whether they come and go, and what makes them better or worse. Understanding your family history is also important because psoriasis tends to run in families. If you have a parent, brother, or sister with psoriasis, you are at higher risk of developing the condition yourself.

Your doctor may ask about recent illnesses, injuries to your skin, stress levels, medications you are taking, and lifestyle factors like smoking or alcohol use. These factors can trigger psoriasis or make it worse. For example, a throat infection caused by streptococcal bacteria can trigger a type of psoriasis called guttate psoriasis, which appears as small, drop-shaped spots and often affects children and young adults.

Skin Biopsy

In most cases, a healthcare provider can diagnose psoriasis just by examining your skin. However, in rare cases where the diagnosis is uncertain or the condition appears severe, your doctor may recommend a skin biopsy. This involves removing a small sample of skin to be examined under a microscope in a laboratory.

A skin biopsy helps confirm the diagnosis and rule out other skin conditions that might look similar to psoriasis. The procedure is typically quick and can often be done in the doctor's office. The skin sample is then sent to a laboratory where specialists examine the tissue structure to look for patterns specific to psoriasis.

Distinguishing Psoriasis from Similar Conditions

One important aspect of diagnosis is telling psoriasis apart from other skin conditions. For instance, psoriasis and eczema can both cause discolored skin, rashes, and itching. However, psoriasis creates thick, scaly plaques, while eczema causes dry, bumpy skin without the same type of scales. Eczema also typically causes more intense itching than psoriasis.

Your doctor will consider all the information from the physical examination, your medical history, and any test results to make an accurate diagnosis. Once psoriasis is confirmed, they will work with you to determine the type and severity of your condition, which guides treatment decisions.

Evaluating for Psoriatic Arthritis

If your doctor suspects you have psoriatic arthritis along with psoriasis, they may refer you to a specialist called a rheumatologist. This doctor specializes in conditions affecting the joints. Diagnosing psoriatic arthritis typically involves a combination of methods, including reviewing your medical history, conducting physical examinations, and ordering blood tests and imaging studies such as X-rays or MRI scans.

If you already have psoriasis, you will usually have an annual assessment to look for signs of psoriatic arthritis. This is important because early treatment can help reduce damage to your joints and preserve your mobility and quality of life.

Diagnostics for Clinical Trial Qualification

Clinical trials test new treatments for psoriasis to determine if they are safe and effective. If you are considering participating in a clinical trial, specific diagnostic tests and evaluations are used to determine whether you qualify to take part in the study.

Baseline Health Assessment

Before enrolling in a clinical trial, researchers need to establish your baseline health status. This typically includes a comprehensive physical examination and detailed review of your medical history. The research team will document the current state of your psoriasis, including the location, extent, and severity of your skin involvement.

Blood tests are commonly performed to assess your overall health and to rule out certain conditions that might make it unsafe for you to participate. These tests may check your liver and kidney function, blood cell counts, and levels of inflammation in your body. Some clinical trials require these baseline measurements to monitor for potential side effects of the treatment being studied.

Severity Assessment Tools

Clinical trials often use standardized tools to measure the severity of psoriasis. These measurements help researchers determine if a treatment is working and allow for consistent comparison of results across different patients and studies. While the specific tools used can vary by trial, they typically involve assessing what percentage of your body is covered by psoriasis and evaluating the characteristics of the plaques.

Your healthcare provider may take photographs of affected areas to document your condition before treatment begins. These images serve as a reference point for tracking changes over time during the trial.

Exclusion Criteria Testing

Clinical trials have specific criteria that determine who can and cannot participate. Diagnostic tests are used to check for conditions that would exclude you from a study. For example, if you have certain infections, like HIV, or active liver disease, you might not be eligible for some trials. Blood tests, and sometimes imaging studies, are used to screen for these conditions.

Some trials may also require testing to confirm you do not have certain types of cancer or other serious health conditions. If you are a woman of childbearing age, pregnancy tests are typically required, as many psoriasis treatments being studied could harm an unborn baby.

Ongoing Monitoring During Trials

Once enrolled in a clinical trial, you will undergo regular diagnostic testing throughout the study period. This monitoring serves two purposes: to track how well the treatment is working and to watch for any side effects or complications. Blood tests are commonly repeated at scheduled intervals to check for changes in your liver function, kidney function, or blood counts that might indicate a problem with the treatment.

You will also have regular examinations of your skin to assess whether your psoriasis is improving, staying the same, or getting worse. The research team will use the same standardized assessment tools throughout the trial to ensure consistent measurements.

If you are interested in participating in a clinical trial for psoriasis, talk to your healthcare provider. They can help you understand what diagnostic tests would be required and whether you might be a good candidate for current studies.

Prognosis and Survival Rate

Prognosis

Psoriasis is a lifelong chronic condition, meaning it stays with you throughout your life. However, this does not mean your symptoms will always be the same. The condition tends to go through cycles, with periods when you have no symptoms or only mild symptoms, followed by periods when symptoms become more severe. These flare-ups can last for a few weeks or months before subsiding again.

The severity of psoriasis varies greatly from person to person. For some people, it is just a minor irritation affecting small patches of skin. For others, it can significantly impact quality of life, causing considerable physical discomfort and emotional distress. The condition can affect your appearance, sleep, ability to concentrate, and overall well-being.

With proper treatment and management, many people with psoriasis can control their symptoms effectively and live full, active lives. Advances in understanding the disease have led to the development of highly effective targeted treatments. While there is no cure for psoriasis, treating it can help improve symptoms and may decrease the associated inflammation throughout your body.

The outlook depends on several factors, including the type and severity of your psoriasis, how well you respond to treatment, and whether you develop related conditions like psoriatic arthritis. People with psoriasis have a slightly higher risk of developing other health conditions, including cardiovascular disease, type 2 diabetes, and depression. Recognition and management of these related conditions is an essential part of your overall care.

Survival Rate

Psoriasis itself is not a life-threatening condition, and people with psoriasis generally have a normal life expectancy. However, the increased risk of certain related conditions, particularly cardiovascular disease, means that comprehensive health management is important. Studies have shown that people with psoriasis may have higher rates of heart disease and stroke compared to the general population, though the exact reasons for this connection are not fully understood.

Taking care of your overall health through regular exercise, maintaining a healthy weight, not smoking, and limiting alcohol consumption can help reduce these risks. Regular monitoring by your healthcare provider for conditions like high blood pressure, high cholesterol, and diabetes is also important for people living with psoriasis.

Did you know?

  1. A phenomenon called Koebner response means that psoriasis can develop at the site of a skin injury, such as a cut, scrape, or even a sunburn, making the location of new patches a diagnostic clue.
  2. Normal skin cells take about 3 to 4 weeks to grow and shed, but in psoriasis, this process happens in just 3 to 7 days, causing the characteristic buildup of scales.
  3. If one identical twin has psoriasis, the other twin is three times more likely to develop it compared to non-identical twins, showing the strong genetic component of the condition.

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Psoriasis

Recruiting trials first

See all 53 trials →
Quick filters

53 clinical trials in this condition

Psoriasis

Recruiting
Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:BelgiumBelgium
  • Participants:0–17 years
  • Substances:Deucravacitinib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Risankizumab
  • Sponsor:Icr Medical S.L.
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:Zasocitinib
  • Sponsor:Takeda Development Center Americas Inc.
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Fluoride (18F)
  • Sponsor:Amsterdam UMC Stichting
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Guselkumab
  • Sponsor:Universitair Ziekenhuis Gent
See all 53 trials →filters applied: condition = Psoriasis

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).